Collegium Pharmaceutical (COLL) Change in Account Payables (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Change in Account Payables of -$3.8 million for Q1 2026, down 127.49% year-over-year from $13.9 million in Q1 2025, and down 225.68% quarter-over-quarter from $3.0 million in Q4 2025.
Collegium Pharmaceutical (COLL) Change in Account Payables (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Change in Account Payables history runs 13 years deep, the most recent figure standing at -$3.8 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 127.49% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$11.0 million (down 313.02% YoY), while the FY2025 annual figure was $6.7 million, up 159.57% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$3.8 million, down from $3.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $13.9 million in Q1 2025, with the low at -$7.0 million in Q2 2025.
- The 5-year median for Change in Account Payables is -$502000.0 (2023), against an average of -$237235.3.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables sank 603.3% in 2024, then surged 648.86% in 2025.
- Collegium Pharmaceutical's Change in Account Payables stood at -$4.1 million in 2022, then soared by 219.6% to $5.0 million in 2023, then tumbled by 83.65% to $810000.0 in 2024, then jumped by 275.93% to $3.0 million in 2025, then plunged by 225.68% to -$3.8 million in 2026.
- Business Quant data shows COLL's Change in Account Payables at -$3.8 million in Q1 2026, $3.0 million in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn | 317,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 317,000.00 |
| Jun 30, 2026 | 317,000.00 |
| Mar 31, 2026 | -3.83 Mn |
| Mar 31, 2026 | -3.83 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | -3.28 Mn |
| Sep 30, 2025 | -3.28 Mn |
| Jun 30, 2025 | -6.96 Mn |
| Jun 30, 2025 | -6.96 Mn |
| Mar 31, 2025 | 13.92 Mn |
| Mar 31, 2025 | 13.92 Mn |
| Dec 31, 2024 | 810,000.00 |
| Dec 31, 2024 | 810,000.00 |
| Sep 30, 2024 | -5.94 Mn |
| Sep 30, 2024 | -5.94 Mn |
| Jun 30, 2024 | -3.61 Mn |
| Jun 30, 2024 | -3.61 Mn |
| Mar 31, 2024 | -2.54 Mn |
| Mar 31, 2024 | -2.54 Mn |